Cambridge MedChem Consulting provides a range of consultancy services in drug discovery and medicinal chemistry. Screening or Focused molecular Library Design. Hit to Lead project supervision. Computational support, in particular virtual screening and QSAR analysis. An online resource for scientists undertaking drug discovery. Training courses on the drug discovery process and medicinal chemistry.

This blog is meant to allow Fragment-based Drug Design Practitioners to get together and discuss NON-CONFIDENTIAL issues regarding fragments. Thirteenth Annual Fragment-based Drug Discovery Meeting. What struck me most was the number of success stories, several involving clinical compounds. A few years back we highlighted.

By Terry Kenakin, Ph. Four Reasons Why You Should Measure and Quantify Signaling Bias in Your Molecules. Most GPCRs are pleiotropically coupled to multiple signaling pathways in cells and the availability of functional assays to separately measure. By Terry Kenakin, Ph. Four Reasons Why You Should Measure and Quantify Signaling Bias in Your Molecules. Discovering a New Class of Anti-Cancer Compounds. By Dana Haley-Vicente, PhD. By Ellen Berg, PhD. By Ellen Berg, PhD.

Epichembio Epigenetics Chemical Biology COST ACTION CM1406. Organic synthesis for chemical biology and medicinal chemistry applications. Improvements in analytical techniques for epigenetics. Profiling and manipulation of microbial biosynthesis pathways. What is different about Action Meetings? Important COST Networking Tool.

Postdoctoral researcher in protein structure and biochemistry. Cancer treatments in the news. Over the past couple of months there have been some slightly hyperbolic headlines about breakthrough new cancer treatments. Continue reading Cancer treatments in the news. Chew it up, spit it out. Build it up, tear it down. Create a free website or blog at WordPress.